Grafa News and Videos — Page 30

MiniMed (NASDAQ:MMED) reported first quarter fiscal 2027 net sales of $843 million, increasing 16.6% year over year on a reported basis and 15.8% organically.

Regis Corporation (NASDAQ:RGS) reported fourth quarter fiscal 2026 revenue of $56 million, down from $60.4 million in the prior-year quarter, while operating income reached $6.6 million.

Novartis (NYSE:NVS) reported positive Phase 3 REMODEL-1 and REMODEL-2 trial results showing remibrutinib reduced annualized relapse rates compared with teriflunomide in adults with relapsing multiple sclerosis.

NIO (NYSE:NIO) reported second quarter 2026 total revenue of RMB32.1 billion (US$4.7 billion), up 69.1% year over year, supported by higher vehicle sales across its brands.

Natera (NASDAQ:NTRA) announced the publication of new data in Blood Neoplasia showing that its Signatera circulating tumor DNA test provided prognostic and predictive information for patients with newly diagnosed and relapsed or refractory lymphoma.

Oil prices increased on Tuesday as renewed fighting between the United States and Iran raised concerns about potential supply disruptions from the Middle East, a major crude-producing region.

Li Auto (NASDAQ:LI) reported August 2026 deliveries of 37,679 vehicles, bringing the company’s cumulative deliveries to 1,801,834 vehicles as of August 31, 2026.

NIO (NYSE:NIO) reported August 2026 deliveries of 35,836 vehicles, up 14.5% year over year, including deliveries from its NIO, ONVO, and FIREFLY vehicle brands.

XPENG (NYSE:XPEV) reported August 2026 vehicle deliveries of 39,107 units, representing a 4% increase compared with the same period last year.

AstraZeneca (NASDAQ:AZN) and Daiichi Sankyo received European Union approval for Enhertu (trastuzumab deruxtecan) combined with pertuzumab as a first-line treatment for adults with unresectable or metastatic HER2-positive breast cancer.